dc.creatorLUCHSINGER,VIVIAN
dc.creatorLUZORO,AMARANTA
dc.creatorMARTÍNEZ,MARÍA JOSÉ
dc.date2010-07-01
dc.date.accessioned2017-03-07T16:29:00Z
dc.date.available2017-03-07T16:29:00Z
dc.identifierhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872010000700003
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/402359
dc.descriptionBackground: Cytomegalovirus (CMV), herpes simplex type 1 (HSV-1) and Epstein Barr virus (EBV) are latent persistent infections. Their reactivation may cause illnesses and death in human immunodefciency virus-infected (HIV) people. World wide seroprevalence of these viruses is over 50%. In Chile, information is not available. Aim: To determine the seroprevalence of CMV, HSV-1 and EBV in Chilean HIV-infected adults. Patients and Methods: A total of 400 HIV- infected adults aged 17 to 67 years (340 males) were studied during 2005 and 2006. CMV, HSV-1 and EBV serum antibodies were measured by enzyme-linked immunoabsorbent assay. Results: The mean lapse from the diagnosis of HIV and serum testing was 67 months and 69.5% patients received antiretroviral therapy. Sixty seven percent of the sample were men who had sex with men (MSM). The seroprevalence for CMV, HSV-1 and EBV were 98.5, 92.2 and 99.7%, respectively. No patient had negative antibodies for all three viruses. Male patients that were negative for HSV-1 had a lower frequency of MSM than the rest of males (26% vs 62%, p < 0.01). Conclusions: There is a high prevalence of positive antibodies against CMV, HSV-1 and EBV in Chilean adults infected with HIV. Specifc diagnostic tests and antiviral therapy should be available for these patients.
dc.formattext/html
dc.languagees
dc.publisherSociedad Médica de Santiago
dc.sourceRevista médica de Chile v.138 n.7 2010
dc.subjectCytomegalovirus
dc.subjectHerpesvirus 1
dc.subjecthuman
dc.subjectHerpesvirus 4
dc.subjecthuman
dc.subjectHIV
dc.titleElevada seroprevalencia de citomegalovirus, virus herpes simplex tipo 1 y virus Epstein Barr en adultos con virus de la inmunodeficiencia humana
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución